150 related articles for article (PubMed ID: 3015006)
1. Influence of acyclovir and bucyclovir on nucleotide pools in cells infected with herpes simplex virus type 1.
Karlsson AH; Harmenberg JG; Wahren BE
Antimicrob Agents Chemother; 1986 May; 29(5):821-4. PubMed ID: 3015006
[TBL] [Abstract][Full Text] [Related]
2. Nucleoside pools of acyclovir-treated herpes simplex type 1 infected cells.
Harmenberg J; Abele G; Wahren B
Antiviral Res; 1985 Apr; 5(2):75-81. PubMed ID: 3160302
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells.
Stenberg K; Larsson A; Datema R
J Biol Chem; 1986 Feb; 261(5):2134-9. PubMed ID: 2418021
[TBL] [Abstract][Full Text] [Related]
4. Influence of cell culture conditions on the inhibition of herpes simplex virus type 1 replication by acyclovir.
Harmenberg J; Wahren B
Intervirology; 1982; 17(4):215-21. PubMed ID: 6290415
[TBL] [Abstract][Full Text] [Related]
5. Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir.
Larsson A; Stenberg K; Ericson AC; Haglund U; Yisak WA; Johansson NG; Oberg B; Datema R
Antimicrob Agents Chemother; 1986 Oct; 30(4):598-605. PubMed ID: 3024562
[TBL] [Abstract][Full Text] [Related]
6. The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo.
Neyts J; Andrei G; De Clercq E
Antimicrob Agents Chemother; 1998 Feb; 42(2):216-22. PubMed ID: 9527762
[TBL] [Abstract][Full Text] [Related]
7. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
Saijo M; Suzutani T; Yoshida I
Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
[TBL] [Abstract][Full Text] [Related]
8. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.
Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2.
Weinberg A; Bate BJ; Masters HB; Schneider SA; Clark JC; Wren CG; Allaman JA; Levin MJ
Antimicrob Agents Chemother; 1992 Sep; 36(9):2037-8. PubMed ID: 1329640
[TBL] [Abstract][Full Text] [Related]
10. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.
Field AK; Davies ME; DeWitt C; Perry HC; Liou R; Germershausen J; Karkas JD; Ashton WT; Johnston DB; Tolman RL
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4139-43. PubMed ID: 6306664
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of acyclovir [9-(2-hydroxyethoxymethyl)guanine] in Epstein-Barr virus-infected lymphoblastoid cell lines.
Colby BM; Furman PA; Shaw JE; Elion GB; Pagano JS
J Virol; 1981 May; 38(2):606-11. PubMed ID: 6264131
[TBL] [Abstract][Full Text] [Related]
12. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates.
Shin YK; Cai GY; Weinberg A; Leary JJ; Levin MJ
J Clin Microbiol; 2001 Mar; 39(3):913-7. PubMed ID: 11230403
[TBL] [Abstract][Full Text] [Related]
13. Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanine.
Ericson AC; Larsson A; Aoki FY; Yisak WA; Johansson NG; Oberg B; Datema R
Antimicrob Agents Chemother; 1985 May; 27(5):753-9. PubMed ID: 2990325
[TBL] [Abstract][Full Text] [Related]
14. Effect of acyclovir on the deoxyribonucleoside triphosphate pool levels in Vero cells infected with herpes simplex virus type 1.
Furman PA; Lambe CU; Nelson DJ
Am J Med; 1982 Jul; 73(1A):14-7. PubMed ID: 6285704
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside metabolism in herpes simplex virus-infected cells following treatment with interferon and acyclovir, a possible mechanism of synergistic antiviral activity.
O'Brien WJ; Coe EC; Taylor JL
Antimicrob Agents Chemother; 1990 Jun; 34(6):1178-82. PubMed ID: 2393279
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
17. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P
Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of herpes simplex virus-induced DNA polymerases and cellular DNA polymerase alpha by triphosphates of acyclic guanosine analogs.
Larsson A; Sundqvist A; Parnerud AM
Mol Pharmacol; 1986 Jun; 29(6):614-21. PubMed ID: 3012321
[TBL] [Abstract][Full Text] [Related]
19. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.
Danve-Szatanek C; Aymard M; Thouvenot D; Morfin F; Agius G; Bertin I; Billaudel S; Chanzy B; Coste-Burel M; Finkielsztejn L; Fleury H; Hadou T; Henquell C; Lafeuille H; Lafon ME; Le Faou A; Legrand MC; Maille L; Mengelle C; Morand P; Morinet F; Nicand E; Omar S; Picard B; Pozzetto B; Puel J; Raoult D; Scieux C; Segondy M; Seigneurin JM; Teyssou R; Zandotti C
J Clin Microbiol; 2004 Jan; 42(1):242-9. PubMed ID: 14715760
[TBL] [Abstract][Full Text] [Related]
20. Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir.
Spector T; Lobe DC; Ellis MN; Blumenkopf TA; Szczech GM
Antimicrob Agents Chemother; 1992 May; 36(5):934-7. PubMed ID: 1324641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
